Lose-It: Using the Energy Gap to Prevent Weight Regain
Study Details
Study Description
Brief Summary
The major challenge in obesity treatment is not producing weight loss but in preventing that weight from being regained. There are many different methods to lose weight, but there are no recommendations for how you can best achieve long-term weight loss maintenance. Despite the method used to reduce one's body weight, very few of these individuals are able to keep their weight off permanently. This project aims to identify how much activity is necessary to prevent weight regain after weight loss.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Increased amount of exercise to maintain weight loss. |
Behavioral: increased exercise
Use prescribed number of minutes of exercise 5-6 days per week to maintain weight loss.
|
Experimental: 2 Combination of Exercise and Diet to maintain weight loss |
Behavioral: Exercise and Diet
Use a combination of exercise and diet to maintain weight loss.
|
Active Comparator: 3 Use diet alone to maintain weight loss. |
Behavioral: diet
Use a prescribed diet to maintain weight loss
|
Outcome Measures
Primary Outcome Measures
- Change in Weight [18 Months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All ethnic groups and both genders
-
Age: Lower age limit: 19 years; Upper age limit: 45 years
-
Body-mass Index: Lower BMI limit: 30 kg/m2; Upper BMI limit: 40 kg/m2 and weight stable within +/- 5 pounds in the last 6 months, and currently at maximum non pregnant body weight (+/- 5%)
-
A negative treadmill stress test or subsequent follow up cardiac testing for cardiac ischemia.
Exclusion Criteria:
-
History of cardiovascular disease, including coronary artery disease, congestive heart failure, & unstable angina, or uncontrolled hypertension ( > 140/90 mm Hg)
-
Currently smoking or stopped smoking in the last 12 months
-
Medications affecting weight, energy intake, or energy expenditure in the last 6 months
-
Use of oral steroids within the last 12 months
-
History of stroke or seizures, thyroid disease, type 1 or 2 diabetes, Cushings syndrome, cerebrovascular, renal disease, hepatic disease, arrhythmias
-
Cancer requiring treatment in the past 5 years, with the exception of skin cancers other than melanoma
-
Infectious diseases: Self-reported HIV positivity or Active tuberculosis
-
Weight loss or weight gain of > 5% in past 6 months for any reason except post-partum weight loss
-
Likely to move away in next 1.5 years
-
Inability to adhere to the program such as inability to increase walking
-
Currently pregnant, lactating or less than 6 months post-partum
-
Major psychiatric disorder: Exclusions related to medications -Antipsychotic agents (these include, but are not limited to: Haldol, Loxitane, Mellaril, Navane, Prolixin, Stelazine, Thorazine, and Trilafon)
-
Current depression by history or Beck Depression Inventory (BDI)
-
Currently being treated for psychological condition
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Center for Human Nutrition | Denver | Colorado | United States | 80262 |
Sponsors and Collaborators
- University of Colorado, Denver
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
- Principal Investigator: Holly R. Wyatt, MD, University of Colorado at Denver Health Sciences Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 06-0369
- R01DK071692